NACL Industries Limited has submitted a statement of deviation or variation for the quarter ended December 31, 2025, along with the Monitoring Agency Report. The company confirms that there was no deviation or variation in the utilization of proceeds from its Rights Issue, which had a total amount raised of ₹24,928.91 Lakhs. The funds were allocated across four main objects: repayment of borrowings (₹10,400.00 Lakhs), investment in its wholly-owned subsidiary NACL Spec-Chem Limited (₹8,300.00 Lakhs), general corporate purposes (₹6,070.92 Lakhs), and issue expenses (₹158.00 Lakhs). The Monitoring Agency Report, prepared by CRISIL Ratings Limited, also confirms that the utilization of funds aligns with the objects stated in the Letter of Offer dated December 08, 2025. The report indicates that no funds were utilized during the quarter ended December 31, 2025, for any of the specified objects, with the initial credit to the Escrow Account occurring on December 31, 2025, and subsequent transfers from January 01 to January 03, 2026. No comments were made by the Audit Committee or the auditors regarding any deviation or variation.